{"changes":[],"country":"US","description":"Pelage Pharmaceuticals develops regenerative medicines for hair loss, led by PP405, a topical small molecule that reactivates dormant hair follicle stem cells. It is for people across all hair types, including those with pattern hair loss and chemotherapy-induced alopecia. Based on a UCLA discovery, PP405 targets stem cells directly, not hormones.","domain":"pelagepharma.com","employees":null,"founded":2019,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"bio","investors":[],"lat":34.053691,"lng":-118.242766,"location":"Los Angeles, US","name":"Pelage Pharmaceuticals","rounds":[{"amountQuarantined":false,"amountUsd":120000000,"currency":"USD","date":"2025-10-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-12","status":"attributed","url":null},"status":"attributed","type":"series-b","url":null}],"slug":"pelagepharma-com","sources":[{"fact":"round","publisher":"crunchbase","retrievedAt":"2026-06-12","status":"attributed","url":null},{"fact":"existence","publisher":"pelagepharma.com","retrievedAt":"2026-06-12","status":"self-reported","url":"https://pelagepharma.com"},{"fact":"description","publisher":"pelagepharma.com","retrievedAt":"2026-06-12","status":"self-reported","url":"https://pelagepharma.com"}],"stage":"series-b+","techStack":["doubleclick floodlight","elementor 4.1.1","google analytics","google tag manager","jetengine","jquery 3.","jquery migrate 3.4.1","mysql","nginx","php","slick","wordpress 7.0"],"totalRaisedUsd":120000000,"updatedAt":"2026-06-12"}